KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) Profit After Tax (2016 - 2026)

Evolent Health has reported Profit After Tax over the past 12 years, most recently at -$429.1 million for Q4 2025.

  • For Q4 2025, Profit After Tax fell 1781.99% year-over-year to -$429.1 million; the TTM value through Dec 2025 reached -$534.5 million, down 767.39%, while the annual FY2025 figure was -$534.5 million, 767.39% down from the prior year.
  • Profit After Tax for Q4 2025 was -$429.1 million at Evolent Health, down from -$20.9 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $3.1 million in Q4 2021 and troughed at -$429.1 million in Q4 2025.
  • A 5-year average of -$37.9 million and a median of -$18.6 million in 2024 define the central range for Profit After Tax.
  • Biggest five-year swings in Profit After Tax: surged 128.7% in 2021 and later crashed 1781.99% in 2025.
  • Year by year, Profit After Tax stood at $3.1 million in 2021, then tumbled by 486.9% to -$11.8 million in 2022, then tumbled by 182.86% to -$33.4 million in 2023, then skyrocketed by 31.75% to -$22.8 million in 2024, then crashed by 1781.99% to -$429.1 million in 2025.
  • Business Quant data shows Profit After Tax for EVH at -$429.1 million in Q4 2025, -$20.9 million in Q3 2025, and -$19.9 million in Q2 2025.